TP53 and neoplasm: Whatever the nature of the transcriptomic data (i.e. microarrays or RNAseq), a brief synthesis of these analyses demonstrates that immune response takes place in p53-mutated tumours whatever the method of p53 status determination (Supplementary Tables S6, S7 and S8).